These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30922943)

  • 1. Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.
    Kim M; Kim JK; Lee J; Kim YS; Lee JL; Kwak C; Jeong CW; Byun SS; Lee SC; Ohyama C; Arai Y; Ahn H
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):819-827. PubMed ID: 30922943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
    Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
    J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy.
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Apr; 15(2):e199-e204. PubMed ID: 27567188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis.
    Kim SH; Song MK; Kim JK; Hong B; Kang SH; Ku JH; Jeong BC; Seo HK
    Cancer Res Treat; 2019 Jul; 51(3):963-972. PubMed ID: 30322230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
    Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
    Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
    Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study.
    Lee J; Lim SH; Chung JH; Song W; Sung HH; Jeong BC; Park SH
    Cancer Res Treat; 2024 Jul; 56(3):871-876. PubMed ID: 38228080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
    Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
    Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
    Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
    Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.